CrossMHV LLC dba Nascence
Early-stage biotechnology company developing a rapid, non-destructive cell culture platform. The platform is described as animal-product-free and designed to increase yields of fragile human cells while preserving cell surface markers. The company indicates readiness to run beta collaborations with research clients.
Industries
N/A
Products
ND2D
A rapid, non-destructive cell culture platform described as animal-product-free and intended to increase yields of fragile human cells while preserving cell surface markers.
ND2D
A rapid, non-destructive cell culture platform described as animal-product-free and intended to increase yields of fragile human cells while preserving cell surface markers.
Services
Pilot / beta collaboration
Collaborative pilot studies to evaluate the non-destructive cell culture platform with external research clients.
Introductory consultation (booking)
Short consultations (30-minute booking option) to discuss services and potential collaboration.
Pilot / beta collaboration
Collaborative pilot studies to evaluate the non-destructive cell culture platform with external research clients.
Introductory consultation (booking)
Short consultations (30-minute booking option) to discuss services and potential collaboration.
Expertise Areas
- Cell culture platform development
- Serum-free cell culture
- Cell expansion for sensitive human cell types
- Cell quality preservation and marker retention
Key Technologies
- Non-destructive cell culture
- Serum-free/animal-product-free culture methods
- High-yield cell expansion
- Cell surface marker preservation methods